APROGEN MEDICINES INC. Funds and ETFs Aprogen Medicines Inc.
Equities
A007460
KR7007460009
Industrial Machinery & Equipment
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,400 KRW | +7.12% |
|
-5.41% | +45.83% |
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +45.83% | 251M | |
| +3.48% | 12.81B | |
| +24.52% | 6.52B | |
| +1.59% | 3.05B | |
| -3.72% | 2.7B | |
| -15.43% | 1.55B | |
| -2.52% | 1.08B | |
| -30.69% | 907M | |
| +4.47% | 678M | |
| -32.52% | 648M |
- Stock Market
- Equities
- A007460 Stock
- Funds and ETFs Aprogen Medicines Inc.
